News and Education for health professionals

Advertisement

Heart Failure Webinar Series - Beating Heart Failure

Don't miss the Beating Heart Failure FREE Webinar Series. Register now to learn more about the latest international clinical guidance on CHF, cutting through the complexity to provide clear pathways to early identification, accurate diagnosis and optimal management.

Cost: Free


Overview:
An estimated 480,000 Australians live with chronic heart failure (CHF) – a condition with a mortality rate comparable to the most common forms of cancer. This webinar will bring GPs fully up to date with the latest international clinical guidance on CHF, cutting through the complexity to provide clear pathways to early identification, accurate diagnosis and optimal management.

Duration: Each webinar goes for 1 hour followed by the interactive Q&A session.

Benefits of attending

  • Understand strategies to delay the development of overt CHF and prevent death before the onset of symptoms are included
  • Gain recommendations for the use of the new compound sacubitril/valsartan, the first in the class of angiotensin receptor neprilysin inhibitors (ARNIs), soon to be PBS listed in Australia
  • Get clarity on this complex area of clinical practice and provide optimal care with confidence to an important and growing patient group
  • Earn two Category 2 RACGP QI&CPD points - please note that points can only be awarded once per user
  • Learn from specialists in your state with education including state specific case studies

29 June

7pm AEST
Dr Scott McKenzie (QLD & NT based specialist)

Webinar concluded

6 July

7pm AEST
Dr Leighton Kearney (VIC & TAS based specialist)

Webinar concluded

2 August

6pm ACST
Christine Burdeniuk (SA & WA based specialist)

25 September

7pm AEST
Dr Aaron Sverdlov

23 October

7pm AEST
Dr Aaron Sverdlov

27 November

7pm AEST
Dr Aaron Sverdlov


Each webinar includes an opportunity for all participants to take part in an interactive Q&A with the host speaker. These education sessions are RACGP accredited. Supported by Novartis.